Sun.Oct 06, 2024

article thumbnail

Sammy Basso, progeria advocate, has died at 28

STAT

We generally don’t think of rare-disease advocacy as funny. But of the many qualities apparent to anyone who met Sammy Basso, a biologist and spokesperson for the progeria patient community, who died suddenly on Saturday at 28, perhaps the most disarming was his ability to find laughter in almost anything. One April Fool’s Day, he posted a video about his doctors putting him on a diet — an absurdity for someone whose genetic disorder prevented him from gaining weight.

145
145
article thumbnail

Study Finds Significant Associations Between Sunlight Exposure, Physical Activity, and Depressive States

Pharmacy Times

According to the authors, being able to identify mood disturbances through passive digital biomarker data can be promising in next-generation predictive, personalized mental health diagnostics.

123
123
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Weekend ICYMI: September 30 to October 4

Drug Topics

In case you missed it, this week we had stories about the availability of the first liquid nonstimulant for ADHD, pharmacy technicians as "vaccine champions," SGLT2i's heart-healthy benefits, and more.

article thumbnail

My Departed Friends’ 3 Questions

The Honest Apothecary

The loss of every loved one is significant, no matter how many people knew or admired the person. But sometimes the Lord brings a person into your life whose loss is felt more deeply and broadly, not because they were more important, but because, in some way, they were more alive. They leave a larger […] The post My Departed Friends’ 3 Questions appeared first on The Honest Apothecary.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

US hospitals prep for supply chain constraints in wake of Baxter International plant closure

Fierce Healthcare

U.S. | U.S. hospitals are taking steps to conserve their supplies of intravenous (IV) fluids as one of the country's biggest manufacturers reduces shipments after Hurricane Helene flooded a major facility in North Carolina.

article thumbnail

Mendaera's $73m raise heads digital financings

pharmaphorum

Recent financings in the digital health sector include a $73 million round for artificial intelligence-enabled robotics player Mendaera, with Qure.ai, VieCure, Rippl, and Univa Health also raising money.Silicon Valley startup Mendaera has earmarked the Series B funding to complete the development of its handheld robotics, medical imaging and AI platform, which is intended for use in commonplace medical procedures like taking biopsies, organ and vascular access, and pain management.

84

More Trending

article thumbnail

Activist investor Starboard builds $1bn Pfizer stake

pharmaphorum

Activist investor Starboard Value has amassed a $1bn stake in pharma group Pfizer and wants strategic changes to restore growth

64
article thumbnail

A Streamlined Platform Process to Accelerate Biotherapeutics from Gene to Clinic

BioPharm

Harmonizing technological innovation and a platform approach in biomanufacturing can reduce time and cost barriers to produce stable, high-expressing antibody-based therapeutics.

40
article thumbnail

Practical Guide: Mastering Process Validation and Quality Control to Produce Products that Scale from Clinic to Commercial

BioPharm

Process validation is essential in biopharmaceutical drug production to ensure product consistency, safety, and quality at every clinical stage, and to effectively reach commercial approval. It minimizes risks, reduces costs, and facilitates a smoother transition from earlier clinical stages to large-scale production, ensuring that drugs are made efficiently safe and effective for patients.

40